Clinical Trial Update: A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pomalidomide plus low-dose dexamethasone to high-dose dexamethasone in refractory/relapsed multiple myeloma; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Dexamethasone (high-dose) (dexamethasone)
• Dexamethasone (low-dose) (dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2014-04-30